@FiercePharma: Top story in FiercePharmaMarketing Weds: Who gets the likes when it comes to job hunting? Think J&J, Novartis and Biogen Idec. Article | Follow @FiercePharma
@TracyStaton: Here's an idea for AZ's full-of-promises execs: Tie pay to opportunity cost. More | Follow @TracyStaton
@EricPFierce: German Merck invests €50M in biologics capacity at Italy plant. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: CIA abandons use of vaccine programs for spying. Story from FierceVaccines | Follow @CarlyHFierce
> Elelyso, an enzyme replacement therapy for Gaucher disease developed by Pfizer ($PFE) and Protalix BioTherapeutics ($PLX), won regulatory approval in Japan. Release
> A Minnesota judge decided not to toss out failure-to-warn claims against Novartis ($NVS), related to its cancer drug Aredia and allegations that it can cause osteonecrosis of the jaw. Report
> Purdue Pharma recruited Saeed Motahari to be its senior vice president and chief commercial officer; Motahari had been a VP of U.S. sales and marketing for AbbVie's ($ABBV) specialty brands business. Release
> The drug distributor Celesio, recently purchased by McKesson Corp. ($MCK), rejigged its management team, with CFO Marion Helmes resigning to be replaced by McKesson's Alain Vachon. Report
> Acura Pharmaceuticals ($ACUR) settled a patent fight with Novartis' generics unit Sandoz, allowing the generics maker to roll out its version of the oxycodone drug Aversion under license from Acura. Report
@FierceMedDev: Neovasc reports higher 1Q revenues, lower expenses and losses. Story | Follow @FierceMedDev
@VarunSaxena2: St. Jude Medical sticking with renal denervation, releases EnligHTN study data at EuroPCR2014. Release | Follow @VarunSaxena2
@MichaelGFierce: Smallest, fastest nanomotor moves drugs and releases them on demand. Story from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Wound-care outfit Healogics is up for grabs with $1B pricetag. Article | Follow @EmilyWFierce
> Cianna picks up $10M to expand its cancer-fighting device. Item
> Wound-care outfit Healogics is up for grabs with $1B pricetag. Report
> Zimmer CEO insists that no salespeople will be cut after Biomet merger. Story
Biotech News
@FierceBiotech: Editors @JohnCFierce, @DamianFierce and @EricPFierce will chat w/ experts and break down #ASCO2014. More to follow. Sponsored by @Covance. | Follow @FierceBiotech
@JohnCFierce: The R&D rankings: Big biotech once again makes Big Pharma look small. Report | Follow @JohnCFierce
@DamianFierce: So, who's going to run $CELG when Bob Hugin hangs it up? More | Follow @DamianFierce
@EmilyMFierce: ICYMI, this week's edition of FierceBiotech Research features lots of ASM2014 news. Report | Follow @EmilyMFierce
> Sarepta bets on DMD drug approval with a $25M plant buy. Article
> Third Rock builds a new West Coast biotech with an eye on cancer drugs. Story
Pharma Manufacturing News
> Global sweep nabs 237 counterfeiting suspects. News
> Moderna names big names to manufacturing advisory board. Item
> Logistics company RXTPL rails at FDA for identifying it in drug seizure report. Article
> Teva recalls drugs made by India's Emcure over lab testing issues. Story
> India to double its drug inspection staff. Report
Vaccines News
> Pandemic flu vaccine research poses risk of unintended release. Story
> Glaxo announces 5-year price freeze for post-GAVI countries. Article
> CIA abandons use of vaccine programs for spying. More
> Sanofi C. diff vaccine shows immune response in PhII trial. Report
> Kymab, Gates Foundation to team up for malaria, HIV antigen discovery. Item
And Finally... Who needs obesity drugs when a grueling, painful diet-and-exercise program works? Report